Clinical "inertia" affects diabetes care – study

Thousands of patients with type 2 diabetes are suffering from "clinical inertia" over adjustments to their medication, it was claimed yesterday.

Researchers found that on average it took 3.7 years from the time when patients started insulin treatment for dosages to be increased.

According to the Leicester University experts, this suggests a lack of tight control of glycaemic levels – putting patients at increased risk of diabetic complications.

The researchers studied the care of some 11,000 patients.

They said that only a third of these patients were given extra medication when they needed it.

They have reported their findings in the journal Diabetes, Obesity and Metabolism.

Researcher Professor Kamlesh Khunti, professor of primary care diabetes & vascular medicine, said: “Of the 11,000 patients we studied, only a third of those needing further medication were actually given it.

“Clinical inertia is a global phenomenon, which is putting people with Type 2 diabetes at further risk of preventable complications associated with the condition.

“Failure by healthcare professionals to intensify medication in the pursuit of tighter glycaemic control is due to a number of complex reasons related to patient and health care professional factors.

"However, we need to make great efforts to reverse these trends and improve patients reaching tight glucose targets from diagnosis of diabetes."

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes, Obesity and Metabolism April 2016 [abstract]

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index